Wednesday, November 1, 2023Free Session Registration
SYMPOSIUM: STANDARDIZATION OF CGM PERFORMANCE EVALUATIONS – DEVELOPMENTS FROM THE IFCC WORKING GROUP ON CGM
7:30
Welcome and Introduction
Guido Freckmann, MD
Institute for Diabetes Technology at Ulm University, Ulm, Germany
Johan H. Jendle, MD, PhD
Örebro University, Örebro, Sweden
7:35
CGM Accuracy: Contrasting CE Marking with the Governmental Controls of the USA and Australia
John Pemberton, BSc
Department of Endocrinology and Diabetes, Birmingham Children’s Hospital, Birmingham Women’s, and Children’s NHS Foundation Trust, Birmingham, UK
7:56
A Scoping Review of CGM Performance Evaluations from the Last 20 Years
Stefan Pleus, PhD
Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany
8:17
Comparison Measurement Approaches for CGM Performance Studies
Rolf Hinzmann, MD, PhD
Roche Diabetes Care, Mannheim, Germany
8:38
Standardized Testing Procedures for the Clinical Performance Evaluation of CGM Systems: A Proposal by the IFCC Working Group on CGM
Guido Freckmann, MD
Institute for Diabetes Technology at Ulm University, Ulm, Germany
9:00
Break
MEET THE PROFESSORS
9:15
Moderator
David T. Ahn, MD
Mary & Dick Allen Diabetes Center, Hoag Memorial Hospital Presbyterian, Newport Beach, California, USA
9:15
Viral N. Shah, MD
Barbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado, USA
9:45
Joseph Wang, PhD
University of California, San Diego, San Diego, California, USA
10:15
Lutz Heinemann, PhD
Science Consulting in Diabetes, Düsseldorf, Germany
PRODUCT THEATER SESSIONS
11:00
Dexcom Presents: Dexcom Technology: Continuous Improvements, Optimization and Near Term Advancements
Peter Simpson
Sr. Vice President, R&D; Dexcom Inc.
11:20
Dexcom Presents: The Growing Use of rtCGM in Non-Insulin Type 2 Diabetes: Clinical Outcomes and Patient Experience in Real-World Practice
Thomas Grace, MD
Head, Clinical Advocacy and Outcomes; Dexcom, Inc.
11:40
Dexcom Presents: Dexcom CGM in Pregnancy: Review of the AiDAPT Study and G7 Accuracy in Pregnancy
Carol J. Levy, MD, CDCES
Professor of Medicine and Obstetrics; Director Mount Sinai Diabetes Center; Associate System Chief for Clinical Research, Division of Endocrinology, Diabetes, and Metabolism; Icahn School of Medicine at Mount Sinai
12:00
Tandem Diabetes Care Presents: Control-IQ Technology Made Easy
Laurel Messer, PhD, RN, CDCES
Senior Director, Translational Research & Applied Science, Tandem Diabetes Care
Thursday, November 2, 2023
WORKSHOP A: DIGITAL HEALTH TOOLS
PANEL 1: INTERACTIVE APPS FOR BEHAVIORAL CHANGE
Can apps modify behavior?
8:00
Moderators
William Polonsky, PhD
Behavioral Diabetes Institute, San Diego, California, USA
Michelle L. Litchman, PhD, FNP-BC, FAANP, FADCES, FAAN
The University of Utah College of Nursing, Salt Lake City, Utah, USA
Panelists
Andrew Farmer, DM, FRCGP
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom
Felix Lee, MPharm, MSc, MBA
Sanofi, Bridgewater, New Jersey, USA
David T. Ahn, MD
Mary & Dick Allen Diabetes Center, Hoag Memorial Hospital Presbyterian, Newport Beach, California, USA
9:40
Break
PANEL 2: TELEHEALTH AND COACHING
How to apply coaching to improve diabetes outcomes?
9:55
Moderators
Warris Bokhari, MBBS
Amazon, Seattle, Washington, USA
David Kerr, MBChB, DM, FRCP, FRCPE
Sutter Health, Santa Barbara, California, USA
Panelists
Wei-An (Andy) Lee, DO
Los Angeles General Medical Center, Los Angeles, California, USA
Anand K. Iyer, PhD, MBA
Welldoc, Inc., Columbia, Maryland, USA
Sacha Uelmen, RDN, CDCES
Association of Diabetes Care & Education Specialists, Chicago, Illinois, USA
11:30
Lunch
WORKSHOP B: METRICS FOR ASSESSING GLYCEMIA AND COMPLICATIONS
PANEL 1: ANALYTICAL AND CLINICAL CGM METRICS
What are the latest metrics for CGM?
12:30
Moderators
Guillermo Umpierrez, MD
Emory University School of Medicine, Atlanta, Georgia, USA
Eda Cengiz, MD, MHS, FAAP
University of California, San Francisco, School of Medicine, San Francisco, California, USA
12:35
The Glycemia Risk Index
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA
12:50
Update on Time in Range
Richard M. Bergenstal, MD
International Diabetes Center, HealthPartners Institute, Minneapolis, Minnesota, USA
13:05
Tight Time in Range
Viral N. Shah, MD
Barbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado, USA
13:20
Continuous Glucose Deviation Interval and Variability Analysis (CG-DIVA)
Manuel Eichenlaub, PhD
Institut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany
13:35
Glycemic Ratio for Critically Ill People
James S. Krinsley, MD
Division of Critical Care, Stamford Hospital, Columbia University College of Physicians and Surgeons, Stamford, Connecticut, USA
13:50
Q&A / Panel Discussion
14:10
Break
PANEL 2: SENSORS FOR DIAGNOSING COMPLICATIONS IN DIABETES
How can technology identify complications of diabetes?
14:25
Moderators
Michael J. McShane, PhD
Department of Biomedical Engineering, Texas A&M University, College Station, Texas, USA
Andjela Drincic, MD
Department of Diabetes, Endocrinology, and Metabolism, University of Nebraska Medical Center, Omaha, Nebraska, USA
14:30
External Eye Screening as an Adjunct to Retinal Screening
Jorge A. Cuadros, OD, PhD
Herbert Wertheim School of Optometry and Vision Science, University of California, Berkeley, Berkeley, California, USA
14:45
Monitoring Exercise for Precision Diabetes
Michael C. Riddell, PhD
Department of Kinesiology & Health Science, Muscle Health Research Centre, York University, Toronto, ON, Canada
15:00
A Multimodal Sensor Panel for Diabetes
Gerard L. Coté, PhD
Department of Biomedical Engineering, Texas A&M University, College Station, Texas, USA
15:15
IEEE 2621: The Diabetes Device Cybersecurity Standard
Ted Osinski
Institute of Electrical and Electronics Engineers, Piscataway, New Jersey, USA
15:30
Racial-Ethnic Disparities in Wearable Diabetes Devices
Devin W. Steenkamp, MBChB
Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA
15:45
Q&A / Panel Discussion
16:05
Adjourn
Friday, November 3, 2023
8:00
Introduction
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA
8:05
iCoDE 1 and 2
Juan Espinoza, MD, FAAP
Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois, USA
8:25
Q&A
SESSION 1: DIABETES DATA SCIENCE
How can data predict and prevent complications of diabetes?
8:30
Moderators
William T. Cefalu, MD
Division of Diabetes, Endocrinology, & Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA
John C. Pickup, MA, DPhil, FRCPath
King’s College London School of Medicine, London, UK
Panelist
Eirik Årsand, PhD
UiT Arctic University of Norway, Tromsø, Norway
8:35
Overview of Diabetes Data Science
Boris Kovatchev, PhD
University of Virginia, Charlottesville, Virginia, USA
8:55
Precision Monitoring in Diabetes
Norbert Hermanns, PhD
Research Institute of the Diabetes Academy Mergentheim (FIDAM), Bad Mergentheim, Germany
9:15
Digital Twinning Technologies in Type 1 Diabetes
Andrea Facchinetti, PhD
Department of Information Engineering, University of Padova, Padova, Italy
9:35
Q&A / Panel Discussion
SESSION 2: NOVEL INDICATIONS FOR CGM
How can people without diabetes benefit from CGM?
9:50
Moderators
Julia K. Mader, MD
Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Austria
Kong Y. Chen, PhD
National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, USA
9:55
CGM in People without Diabetes
Tracey L. McLaughlin, MD, MS
Stanford University School of Medicine, Stanford, California, USA
10:10
CGM in Pregnancy
Stephanie A. Fisher, MD, MPH
Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
10:25
CGM in Kidney Disease
Connie M. Rhee, MD, MSc
VA Greater Los Angeles Healthcare System, Los Angeles, California, USA and David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA
10:40
The Use of CGM in the Hospital
Kathleen M. Dungan, MD, MPH
The Ohio State University, Columbus, Ohio, USA
10:55
Q&A / Panel Discussion
11:10
Break
SESSION 3: REGULATION OF DIABETES DEVICES AND DRUGS
What are new trends in FDA regulation of diabetes devices and drugs?
11:25
Moderators
Alberto Gutierrez, PhD
NDA Partners LLC, Bethesda, Maryland, USA
Naomi Schwartz, MS
Medcrypt, Inc., San Diego, California, USA
11:30
Update in Digital Health Regulation
Matthew C. Diamond, MD, PhD
Center for Devices and Radiological Health, United States Food and Drug Administration, Silver Spring, Maryland, USA
11:40
Medical Device Cybersecurity
Jessica Wilkerson, JD
Center for Devices and Radiological Health, United States Food and Drug Administration, Silver Spring, Maryland, USA
11:50
Regulatory Considerations for Comparator Glucose Technology
Deanna Bousalis, PhD
Center for Devices and Radiological Health, United States Food and Drug Administration, Silver Spring, Maryland, USA
12:00
Regulation of Diabetes Drugs
Zan Fleming, MD
Kinexum, Harpers Ferry, West Virginia, USA
12:15
Q&A / Panel Discussion
12:30
Lunch
SESSION 4: PUMP TECHNOLOGY (Non-Accredited Education)
What are the challenges to building a commercially successful insulin pump?
13:00
Moderators
Robert A. Gabbay, MD, PhD
American Diabetes Association, Arlington, Virginia, USA
Douglas Muchmore, MD
La Jolla Endo, LLC, La Jolla, California, USA
13:05
Advances in Infusion Sets
Sarnath Chattaraj, PhD
Medtronic Diabetes, Northridge, California, USA
13:15
Advances in Infusion Set Needles and Cannulas
Jeffrey Joseph, DO
Jefferson Artificial Pancreas Center, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, USA
13:25
Combining Glucose Monitoring and Insulin Infusion in an Integrated Device: Challenges and Solutions
Lutz Heinemann, PhD
Science Consulting in Diabetes, Düsseldorf, Germany
13:35
Determining Flow Rate from an Insulin Pump
Ralph Ziegler, MD
Diabetes Clinic for Children and Adolescents, Muenster, Germany
13:45
Last Things First – the Importance of Design for Manufacturability
Michael Schoemaker, PhD
Pharmasens AG, Biel, Switzerland
13:55
Q&A / Panel Discussion
SESSION 5: BLOOD GLUCOSE MONITORING TECHNOLOGY (Non-Accredited Education)
What is the role of BGM in various parts of the world?
14:10
Moderators
Hubert W. Vesper, PhD
Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Halis K. Aktürk, MD
Barbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado, USA
14:15
Reference Comparators for BG Sensor Testing
Timothy S. Bailey, MD, FACE, CPI
AMCR Institute, Escondido, California, USA
14:25
Interfering Substances
Andreas Pfützner, MD, PhD
Pfützner Science and Health Institute, Mainz, Germany
14:40
Platforms to Present Glucose Data
Mark A. Clements, MD, PhD, CPI, FAAP
Children's Mercy Hospitals & Clinics, Kansas City, Missouri, USA
14:55
The Role of BGM in Today's World
Yong Mong Bee, MBBS, MRCP(UK), FRCP Edin
Department of Endocrinology, Singapore General Hospital, Singapore
15:10
Q&A / Panel Discussion
15:20
Break
SESSION 6: EMERGING AID TECHNOLOGY
What are the features of a successful AID algorithm?
15:35
Moderators
Jeffrey Joseph, DO
Jefferson Artificial Pancreas Center, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, USA
Carol Levy, MD, CDCES
Division of Endocrinology, Diabetes, and Metabolism, Icahn School of Medicine at Mount Sinai, New York City, New York, USA
15:40
Bihormonal Systems: Automating Both Insulin and Glucagon Delivery
Steven J. Russell, MD, PhD
Massachusetts General Hospital Diabetes Research Center, Boston, Massachusetts, USA
15:50
The Loop Algorithm
Rayhan A. Lal, MD
Stanford University, Stanford, California, USA
16:00
AID systems. Are we there yet? A clinician’s perspective.
David N. O'Neal, MD, FRACP, FRCP (Edin)
University of Melbourne, Melbourne, VIC, Australia
16:10
Improving the Performance of an AID system with SGLT2i
Ahmad Haidar, PhD
McGill University, Quebec, Canada
16:20
Personal Patient Experience with Loop
Patient 1
16:25
Personal Patient Experience with Loop
Patient 2
16:30
Q&A / Panel Discussion
16:45
Adjourn
Saturday, November 4, 2023
SESSION 7: DRUGS FOR DIABETES
Which new drugs or indications for diabetes look promising?
8:00
Moderators
Mohammed E. Al Sofiani, MBBS, MSc
King Saud University, Riyadh, Saudi Arabia / Johns Hopkins University, Baltimore, Maryland, USA
Signe Schmidt, MD, PhD
Steno Diabetes Center Copenhagen (SDCC), Copenhagen, Denmark
8:05
Gold Student Award Winner: DR-CIB: an Algorithm for the Preventive Administration of Corrective Insulin Boluses in Type 1 Diabetes based on Dynamic Risk Concept and Patient-Specific Timing
Elisa Pellizzari, MSc
University of Padova, Padova, Italy
8:20
Tirzepatide / Semaglutide for Obesity and T2DM
Eric Zijlstra, PhD
Profil, Neuss, Germany
8:35
Weekly Insulin for Type 1 and Type 2 Diabetes
Ronald Goldenberg, MD, FRCPC, FACE
LMC Diabetes & Endocrinology, Concord, Ontario, Canada
8:50
Inhaled Insulin
Alfonso Galderisi, MD, PhD
Yale University, New Haven, Connecticut, USA
9:05
Tzield/Teplizumab - Why and for Whom?
Stephen E. Gitelman, MD
Division of Endocrinology, Department of Pediatrics, University of California, San Francisco, San Francisco, California, USA
9:20
Q&A / Panel Discussion
SESSION 8: ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING (Non-Accredited Education)
What is the role of AI/ML in diabetes management?
9:35
Moderators
Boris Kovatchev, PhD
University of Virginia, Charlottesville, Virginia, USA
Riccardo Bellazzi, PhD
Università di Pavia, Pavia, Italy
9:40
Bridge to Artificial Intelligence
Xujing Wang, PhD
Division of Diabetes, Endocrinology, & Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA
9:55
Consensus Guidelines for Using Artificial Intelligence and Machine Learning to Improve Glucose Management in Diabetes: Best Practices, Pitfalls and Opportunities
Peter G. Jacobs, PhD
Oregon Health & Science University, Portland, Oregon, USA
10:10
Uncertainty-aware Nocturnal Hypoglycemia Prediction in People with Type 1 Diabetes on Multiple Daily Injections
Clara Mosquera-Lopez, PhD
Oregon Health & Science University, Portland, Oregon, USA
10:25
Artificial Intelligence for Treating Diabetes
Moshe Phillip, MD
Schneider Children's Medical Center of Israel, Petah Tikva, Israel
10:40
Q&A / Panel Discussion
10:55
Break
SESSION 9: NOVEL ANALYTES FOR DIABETES (Non-Accredited Education)
What should be measured for diabetes besides blood glucose?
11:15
Moderators
Guillermo Arreaza-Rubín, MD
Division of Diabetes, Endocrinology, and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA
Alan H.B. Wu, PhD
University of California, San Francisco, San Francisco, CA, USA
11:20
Noninvasive Glucose Monitoring - When Will It Arrive?
Mark A. Arnold, PhD
The University of Iowa, Iowa City, Iowa, USA
11:35
Continuous Ketone Monitoring
Shridhara Alva, PhD
Abbott Diabetes Care, Alameda, California, USA
11:50
Biomarkers Screening for Asymptomatic Heart Failure
Ambarish Pandey, MD
UT Southwestern Medical Center, Dallas, Texas, USA
12:05
Q&A / Panel Discussion
12:20
Lunch
SESSION 10: NEW TECHNOLOGY DEVELOPMENTS IN COMMERCIAL CGMS (Non-Accredited Education)
What is new in CGM technology?
12:50
Moderators
Nestoras Mathioudakis, MD, MHS
Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Elias K. Spanakis, MD
Baltimore VA Medical Center and School of Medicine, University of Maryland, Baltimore, Maryland, USA
12:55
Abbott Technology
Anila Bindal, MD
Abbott Diabetes Care, Alameda, California, USA
13:07
Dexcom Technology
Danny Cherñavvsky, MD
Dexcom, Inc., San Diego, California, USA
13:19
Medtronic Technology
Robert Vigersky, MD
Medtronic, Washington, D.C., USA; Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA
13:31
Senseonics Technology
Hari Sree, PhD
Senseonics Inc., Germantown, Maryland, USA
13:43
Pacific Diabetes Technologies
Thomas Seidl, PhD
Pacific Diabetes Technologies, Portland, Oregon, USA
13:55
Q&A / Panel Discussion
SESSION 11: SKIN PHYSIOLOGY (Non-Accredited Education)
How does diabetes affect skin health?
14:10
Moderators
Gerald R. Sydorak, MD, FACS
Seton Medical Center, Daly City, California, USA
Bijan Najafi, PhD, MSc
Baylor College of Medicine, Houston, Texas, USA
14:15
Device Induced Inflammation
Ulrike Klueh, PhD
Department of Biomedical Engineering, Integrative Biosciences Center, Wayne State University, Detroit, Michigan, USA
14:30
Identifying and Preventing Lipohypertrophy
Jane Jeffrie Seley, DNP, MPH, MSN, GNP, BC-ADM, CDCES
Weill Cornell Medicine, Division of Endocrinology, Diabetes & Metabolism, New York City, New York, USA
14:45
Effects of Infusion Pumps
Jannet Svensson, MD, PhD
Steno Diabetes Center Copenhagen, Herlev, Denmark
14:55
Glycemic and Geriatric Challenges: Understanding Wound Healing Dynamics in Frail Diabetic Patients
Bijan Najafi, PhD, MSc
Baylor College of Medicine, Houston, Texas, USA
15:05
Q&A / Panel Discussion
15:20
Break
SESSION 12: HOT TOPICS
What are promising new technologies for diabetes?
15:40
Moderators
Umesh Masharani, MB, BS
University of California, San Francisco, San Francisco, California, USA
Geoff Chase, PhD
University of Canterbury, Christchurch, New Zealand
15:45
How Can Technology Improve Patient Adherence to Offloading?
Bijan Najafi, PhD, MSc
Baylor College of Medicine, Houston, Texas, USA
15:55
Peritoneal Insulin Delivery
Diane J. Burgess, PhD
University of Connecticut, Storrs, Connecticut, USA
16:05
Machine Learning for Multiple Sensor Datastreams and Explainable AI
Ali Cinar, PhD
Illinois Institute of Technology, Chicago, Illinois, USA
16:15
Green Diabetes
Ed Krisiunas, MLS(ASCP), MPH
WNWN International, Burlington, Connecticut, USA
16:25
Q&A / Panel Discussion
SESSION 13: LIVE DEMONSTRATION
What is a new carbohydrate dispensing product for diabetes?
16:40
Moderators
Dorian Liepmann, PhD
University of California, Berkeley, Berkeley, California, USA
Jane Jeffrie Seley, DNP, MPH, MSN, GNP, BC-ADM, CDCES
Weill Cornell Medicine, Division of Endocrinology, Diabetes & Metabolism, New York City, New York, USA
16:45
House of Carbs - Personalized Carbohydrate Dispenser for People with Diabetes
Eirik Årsand, PhD
UiT Arctic University of Norway, Tromsø, Norway
Pietro Randine
UiT Arctic University of Norway, Tromsø, Norway
17:00
Closing Statement and Adjourn
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA
Tuesday, November 7, 2023Free Session Registration
VIRTUAL POSTER SESSION (Non-Accredited Education)
Oral presentation and moderated discussion of the top abstracts submitted to DTM 2023
8:30-12:30